A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study

BACKGROUND: Platinum-based combinations are the standard second-line treatment for platinum-sensitive ovarian cancer (OC). This randomized phase II study was undertaken in order to compare the combination of carboplatin and pegylated liposomal doxorubicin (LD) with carboplatin and paclitaxel (CP) in...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Bafaloukos, Dimitrios, Linardou, Helena, Aravantinos, Gerasimos, Papadimitriou, Christos, Bamias, Aristotelis, Fountzilas, George, Kalofonos, Haralabos P, Kosmidis, Paris, Timotheadou, Eleni, Makatsoris, Thomas, Samantas, Epaminondas, Briasoulis, Evangelos, Christodoulou, Christos, Papakostas, Pavlos, Pectasides, Dimitrios, Dimopoulos, Athanasios M
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2010
Témata:
Research article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2823653/
https://ncbi.nlm.nih.gov/pubmed/20055981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-8-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky